Asthma Allergy Immunology

Guidelines for Authors

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

Asthma Allergy Immunology uses a double-blind peer review system where reviewers do not know the names of the authors, and the authors do not know who reviewed their manuscript. Please, do not use proprietary names in the main text or in the Abstract. The Ethics Statement should be anonymized.

  • Cover letter
  • Author Contribution Form
  • Copyright Transfer Form
  • Title Page
  • Title
  • Running title
  • Author names and affiliations
  • Corresponding author contact information
  • Funding Statement
  • Disclosure Statement
  • Abstract (All manuscripts except “Letters to the Editor and Editorials” should include abstract.)
  • Key Words (two to five key words)
  • Main Text (Committee of Ethics Approval should be included for all research articles in the method section.)
  • Acknowledgments (If applicable, the acknowledgments should be placed after the Discussion.)
  • References
  • Tables (at the end of the manuscript in the same file as the text)
  • Figures (Each figure should be loaded as a separate file.)
  • Figure Legends (Legends for figures, graphics and pictures should be typed in the manuscript file, on a separate page after the tables.)

Guide for Authors

1. Asthma Allergy Immunology is the periodical journal of the Turkish National Society of Allergy and Clinical Immunology, which is published three times a year.

2. The aim of the journal; is to present advances in the field of allergic diseases and clinical immunology to the readers. In accordance with this goal, manuscripts in the format of research article, review article, case report, letters to the editor and editorials about allergic diseases and clinical immunology are published in the journal.

3. The official language of the journal is English.

4. All manuscripts submitted for publication should comply with “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” produced and updated by the International Committee of Medical Journals Editors (www.icmje.org).

5. ETHICAL PRINCIPLES. Compliance with the Declaration of Helsinki Principles (http://www.wma.net/ en/30publications/10policies/b3/index.html) is accepted as the policy of Asthma Allergy Immunology. Therefore, all manuscripts concerning human subjects must contain a statement in the “Materials and Methods” section, indicating that the study was approved by the Institutional Review Board. All manuscripts dealing with animal subjects must contain a statement indicating that the study was performed according to “The Guide for the Care and Use of Laboratory Animals” (www.nap.edu/catalog/5140.html) with the approval of the Institutional Review Board, in the “Materials and Methods” section. The Editor may ask for a copy of the approval document.

6. The Committee of Ethics is an institutional committee that reviews the methods and their ethical appropriateness of researches. This committee provides an approval and document this approval as an official record by reviewing the methods of researches. This journal accepts the International Standards for COPE (Committee on Publication Ethics).

In studies requiring ethics committee permission, information about the approval (name of the board, date and number) should be included in the method section. In case reports, a note about informed consent form signed by the patient should be included in the article.

Researchers who are not affiliated with any institution should apply to the Committee of Ethics of the universities in their provinces for the Committee of Ethics approval of their articles. In articles derived from theses and dissertations, it is sufficient to submit the Committee of Ethics approval document received for the thesis or dissertations. A separate Committee of Ethics approval document is not expected for the candidate article. Institutional and individual research permissions obtained in the scope of the research are not accepted as a committee of ethics approval.

7. The editor has the right to format or reject the manuscripts which do not follow the rules or send them back to the author for correction. Authors who wish to withdraw their manuscripts need to state this to the editor in written form.

8. Submitted papers are reviewed by the editor, the associated editors, and at least two reviewers. The editor and associated editors may decide to send the manuscript to a third reviewer. The editors are the complete authority regarding reviewer selection. The reviewers may be selected from the advisory board or independent national or international reviewers may be selected when required for the topic of the manuscript.

9. The dates of received and accepted of the manuscript are stated in the beginning of the manuscript when published in the journal.

10. The manuscripts should be submitted via online manuscript evaluation system (www.aai.org.tr).

11. COVER LETTER. The cover letter should explain why your work is perfect for their journal and why it will be of interest to the journal’s readers.

In your submission cover letter, include the following information:

  • Address the editor
  • Manuscript’s title
  • Article type
  • Name of the journal
  • Statement that your paper has not been previously published and is not currently under consideration by another journal
  • Brief description of the research you are reporting in your paper, why it is important, and why you think the readers of the journal would be interested in it
  • Corresponding author contact information
  • Confirmation that you have no competing interests to disclose

12. AUTHORSHIP CONTRIBUTION STATEMENT. This author contribution statement form is signed by corresponding author of the manuscript on behalf of all authors. The form should be e-mailed to insuyilmaz@gmail.com after being scanned simultaneous with the online upload of the manuscript.

13. MANUSCRIPT PREPARATION (GENERAL POINTS). The manuscript text should be written in Times New Roman font, 10 point-type, double-spaced with 2 cm margins on the left and right sides. The article should be prepared with IBM compatible computer programs (Microsoft Windows, Word 98). All sections of the manuscripts should start on a new page. Pages should be numbered consecutively, beginning with the abstract. Page numbers should appear at the bottom right corner of every page. The main text file should not contain any information regarding author names and affiliations.

14. ABBREVIATIONS. Abbreviations should be internationally accepted and should be defined accordingly in the text in parenthesis when first mentioned and used in the text. The abbreviated form should be used all throughout the article. “How To Write and Publish Scientific Articles” (http://journals.tubitak.gov.tr/kitap/maknasyaz/) can be referred for international abbreviations.

15. TITLE PAGE. The title page of the manuscript should include title of the article, running title not exceeding 40 characters including spaces as well as the full names, surnames and academic degrees of the authors. The department, division and institution of the authors should be indicated. The Journal requires all authors to acknowledge, on the title page of the manuscript, all funding sources that supported their work and any commercial associations that might pose a conflict of interest. The Corresponding Author is responsible for obtaining each authors statement and all authors should see and approve the complete disclosure before submission to the Journal. The manuscript which has been presented previously as an abstract in any congress or symposium may be mentioned on condition with the statement of the date and the place of the meeting in the title page. Title page should also include address, e-mail, phone and fax number of the corresponding author. Title page should be submitted as a separated file.

16. ABSTRACT. All manuscripts except “Letters to the Editor and Editorials” should include abstract. Abbreviations should be avoided in abstract. References, figures, tables and citations should not be used in the abstract. There should be two to five key words complying with the Index Medicus medical Subject Headings (MeSH). Refer to www.nlm.nih.gov/mesh/MBrowser.html for key words.

17. RESEARCH ARTICLES. Research Articles should include; title, structured abstract (limited to 300 words structured as Objective, Materials and Methods, Results and Conclusion), and key words. Other sections of the manuscript should include Introduction, Materials and Methods, Results, Discussion, Acknowledgement (if required) and References. Research articles should not exceed 5000 words and 40 references.

18. REVIEW ARTICLES. Manuscripts in the form of “Reviews” are accepted when “invited” since 2009. In case of wishing to write a review about a current topic without being “invited”, the editor should be contacted before the manuscript is submitted. Review Articles should include; title, abstract, and key words. The abstract should be prepared as one paragraph and limited to 300 words. Structured abstract is not required. Number of references should be limited to 40 if possible. Manuscripts must be no longer than 5000 words.

19. CASE REPORTS. Case reports should include title, abstract, key words, introduction, case presentation, discussion and references. Introduction and discussion sections of the case reports should be short and concise. Structured abstract is not required. Case reports should not exceed 1500 words and the number of references should not exceed 20.

20. LETTERS TO THE EDITOR. The Asthma Allergy Immunology considers two types of Letters to the Editor. An abstract is not required.

1) Correspondence Letters: Correspondences are letters regarding articles published in Asthma Allergy Immunology. Letters should be received less than six months after publication of the original work in question. If the correspondence is considered acceptable, a response will be requested from the authors of the referenced Asthma Allergy Immunology article. Upon review and approval by the Editor and peer-reviewed,  the Correspondence and relevant Reply will both be published together. The Correspondence manuscripts must have a short, relevant title, distinct from the title of the referenced article. All Replies should have the title "Reply to first author's name. Correspondence Letters should be no longer than 500 words and cite no more than 6 references. Illustrations and tables are discouraged.

2) Short Reports: Short reports should include research results in the related field in a short and concise form or a discussion of patient cases. Short reports should be no longer than 1500 words,  and no more than 20 references.  Number of tables should be limited to 2 and that of the figure/graphic/picture should be limited to 1.

21. EDITORIALS. All editorials topics must be expressing objective opinions, experiences or perspectives on an important area relevant to the Asthma Allergy Immunology. Editorials are commissioned by the Editorial board. Editorials are limited to 1000 words and contain no more than 15 references and  may include maximum 1 table and 1 figure.

22. ACKNOWLEDGMENTS. All acknowledgments should be grouped into one paragraph and placed after the Discussion. All the entities that provide contribution to the technical content, data collection and analysis, writing, revision etc. of the manuscript and yet do not meet the criteria to be an author should be mentioned in the acknowledgement part. If the contribution of the sponsor is only in the form of financial support, this should be stated in the “Acknowledgement” section. If the sponsor has participated in the methods, statistical analysis or manuscript preparation, this contribution should also be stated in the “Materials and Methods” section. If there is no conflict of interest it should also be stated.

23. REFERENCES. Data and manuscript not published yet should not be included among the references. These should be stated in the main text as “author(s), unpublished data, year”.

Reference numbers should be referred to in parentheses at the end of sentences within the text and references should be numbered consecutively in the order they are mentioned in the text. Journal names should be abbreviated as listed in “Index Medicus” or in “ULAKBIM/Turkish Medical Index”. References should be typed in consistence with the following examples. National references should be used as much as possible.

If the reference is a journal;

Author(s)’ surname and initial(s) of the first name (all authors if the number of authors are 6 or less, first 6 authors if the number of authors of an article is more than 6 followed by “et al.”).Title of the article, title of the manuscript abbreviated according to Index Medicus (http://www.ncbi.nlm.nih.gov/sites/entrez/query. fcgi?db=nlmcatalog). Year;Volume:First and last page number.

Example: Benson M, Reinholdt J, Cardell LO. Allergen-reactive antibodies are found in nasal fluids from patients with birch induced intermittent allergic rhinitis, but not in healthy controls. Allergy 2003;58:386-93.

If the reference is a journal supplement;

Author(s)’ surname and initial(s) of the first name. Title of the article. Title of the manuscript abbreviated according to Index Medicus (http://www.ncbi.nlm.nih.gov/sites/entrez/ query. fcgi?db=nlmcatalog). Year;Volume (Suppl. Supplement number):First and last page number.

Example: Queen F. Risk assessment of nickel carcinogenicity and occupational lung cancer. Envirol Health Perspect 1994;102 (Suppl. 1): 2755-2782.

If the reference is a book;

Author(s)’ surname and initial(s) of the first name. Title of the book. Edition number. City of publication: Publisher, Year of Publication.

Example: Ringsven MK, Bond N. Gerontology and leadership skills for nurses. 2nd ed. Albany, NY: Delmar, 1996.

If the reference is a book chapter;

Surname and initial(s) of the first name of the author(s) of the chapter. Title of the chapter. In: Surname and initial(s) of the first name(s) of the editor(s) (ed) or (eds). Title of the book. Edition number. City of publication: Publisher, Year of publication: First and last page numbers of the chapter.

Example: Phillips SJ, Whistant JP. Hypertension and stroke. In: Laragh JH, Brenner BM (eds). Hypertension: Pathophysiology, Diagnosis and Management. 2 nd ed. New York: Raven P, 1995:466-78.

If the reference is an article presented in a meeting;

Author(s)’ surname and initial(s) of the first name (all authors if the number of authors are 6 or less, first 6 authors if the number of authors of an article is more than 6 followed by “et al.”).Title of the article, If applicable In:Surname and initial(s) of the first name(s) of the editor(s) (ed) or (eds). Title of the book. Title of the meeting; Date; City of the meeting; Country. Publisher; Year. Page numbers.

Example: Bengtsson S, Solheim BG. Enforcement of data protection, privacy and security in medical informatics. In: Lun KC, Degoulet P, Piemme TE, Reinhoff O (eds). MEDINFO 92. Proceedings of the 7th World Congress on Medical Informatics; 1992 Sep 6-10; Geneva, Switzerland. North-Holland; 1992. p. 1561-5.

If the reference is an online journal;

Author(s)’ surname and initial(s) of the first name (all authors if the number of authors are 6 or less, first 6 authors if the number of authors of an article is more than 6 followed by “et al.”).Title of the article, title of the manuscript abbreviated according to Index Medicus Year; Volume (Number). Available from:URL address. Accessed date:day.month.year.

Example: Morse SS. Factors in the emergence of infectious disease. Emerg Infect Dis 1995;1(1). Available from: URL:http://www/cdc/gov/ncidoc/EID/eid.htm. Accessed date:25.12.1999.

If the reference is a website;

Name of the web site. Access date. Available from: address of the web site.

World Health Organization (WHO). Access date: 9 July 2008. Available from: http://www.who.int

If the reference is a thesis;

Author’s surname and initial of the first name. Title of the thesis (thesis). City; Name of the university (if it is a university); Year.

Example: Erkan ML. Investigation of clinical and laboratory features of asthma patients with aspirin sensitivity (Thesis). Ankara: Hacettepe Üniversity; 1989.

24. TABLES AND FIGURES. Tables, figures, graphics and pictures should be numbered with Arabic numbers in order of reference in the text. Each table should be prepared with double spacing on a separate page, one table per page, at the end of the manuscript in the same file as the text. A brief title should be provided directly above each table. Authors should place explanatory matter at the bottom of the table, not in the heading. Explanations should be made for all nonstandard abbreviations at the bottom of the table. The following symbols should be used for abbreviations in sequence: *,†,‡,§,||,¶,**,††,‡‡. Each table should be cited in text.  

Figures should be either professionally drawn or photographed, and these items should be submitted as photographic-quality digital images. Figures should be submitted in a format that will produce high-quality image (for example, JPEG or GIF). Authors should control the images of such files on a computer screen before submitting them to be sure they meet their own quality standards. Please, do not put a caption above a figure. The title for a figure should be described only in the figure legend, and not appear on the figure. Labels should be placed within the body of the figure. Figures explanations of symbols, arrows, numbers or letters should appear only in the figure legend, and not in the actual figure. Each figure should be loaded as a separate file.

X-ray films, scans and other diagnostic images, as well as pictures of pathology specimens should be submitted as sharp, glossy, black-and-white or color photographic images. Letters, numbers, and symbols on figures should be clear and consistent throughout, and large enough to remain legible when the figure is reduced for publication. Figures should be made as self-explanatory as possible. For recognizable photographs of patients, signed releases of the patient or of his/her legal representative should be submitted; otherwise, patient names or eyes must be blocked out to prevent identification.

25. ILLUSTRATIONS LEGENDS. Legends for figures, graphics and pictures should be typed in the manuscript file, on a separate page after the tables. They should not appear in the figure files. When symbols, arrows, numbers or letters are used to identify parts of illustrations, should be defined clearly in the legend.

If quoted parts, tables, figures, graphics, pictures etc. exist in the manuscript, the authors should obtain written permission from the author and copyright holder and indicate this.

26. REVISED MANUSCRIPTS

If authors choose to revise their manuscript, they should resubmit the revised version marked R1. Revised manuscripts must be submitted within 45 days from the date of the decision letter. If the revised version of the manuscript is not submitted within the allocated time, the revision option may be cancelled. If the submitting author(s) believe that additional time is required, they should request this extension before the initial 45-day period is over.

Revised manuscripts must:

1) A Responses to Comments document that includes point-by-point responses to the comments made by the Reviewers. In each response, indicate where changes were made in the manuscript.

2) Provide both clean and marked versions of files that have been revised. 

  • A Marked Manuscript: The preferred method of indicating changes is Microsoft Word's Track Changes feature.
  • A Clean Manuscript: The Unmarked Manuscript should be your revised manuscript just as you intend it for publication (if it is accepted).

27. COPYRIGHT TRANSFER FORM. Scientific and legal responsibility of the published articles belong to the authors. Authors are responsible for the ideas and comments in the manuscript as well as the accuracy of the references. Turkish National Society of Allergy and Clinical Immunology, the Editor, the Associated Editors or the publisher do not accept any responsibility for the published articles. The copyright of the articles accepted for publication belong to the Turkish National Society of Allergy and Clinical Immunology.This Copyright Transfer Form is signed by corresponding author of the manuscript on behalf of all authors. The form should be e-mailed to insuyilmaz@gmail.com after being scanned simultaneous with the online upload of the manuscript 

28. PUBLICATION CHARGES. There are no submission fees, publication fees or page charges for this journal. There is no royalty payment to the authors.

29. CITATION. Asthma Allergy Immunology

30. PUBLICATION RIGHTS. Publication rights of Instructions to Authors of Asthma Allergy Immunology belong to the Bilimsel Tip Yayinevi and the Turkish National Society of Allergy and Clinical Immunology and all rights are reserved.

31. Manuscripts, figures and tables published in Asthma Allergy Immunology may not be reproduced in part or completely, archived in a retrieval system or used for advertising purposes without a written permission from the Turkish National Society of Allergy and Clinical Immunology. Quotations may be used in scientific articles as long as they are referred. Related company is responsible for the content of the advertisements published in the journal. The Asthma Allergy Immunology is available online free of charge and contents of the journal can be accessed from the journal’s website at: www. aai.org.tr.

CONTACT
İnsu Yılmaz, MD, Professor (Editor)
Address: Erciyes University School of Medicine,
Department of Chest Diseases,
Division of Immunology and Allergic Diseases,
Kayseri, Turkey
E-mail: insuyilmaz@gmail.com